Planning

Oncotype DX Testing

NHS GREATER GLASGOW AND CLYDE

This public procurement record has 1 release in its history.

Planning

13 May 2019 at 00:00

OJEU - F1 - Prior Information Notice
Summary of the contracting process

NHS Greater Glasgow and Clyde is planning a procurement for Oncotype DX Testing, a service that focuses on advanced genomic science to optimise treatment decisions for breast cancer patients. This tender is in the planning stage, with a total estimated value of £875,000. The process is set for communication on and after 1st July 2019, and the services are required to be delivered across multiple locations within the Glasgow region, including NHS Greater Glasgow and Clyde facilities.

This tender presents significant opportunities for businesses specialising in genomic testing and health services, particularly those with expertise in oncological diagnostics. Companies that can provide advanced testing solutions and demonstrate an understanding of tailored cancer treatment strategies would be well-positioned to compete. Engaging with this procurement opportunity could help these businesses expand their market presence and contribute to improved healthcare outcomes.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Oncotype DX Testing

Notice Description

NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

Lot Information

Lot 1

NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000583062
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
OJEU - F1 - Prior Information Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85121200 - Medical specialist services

Notice Value(s)

Tender Value
£875,000 £500K-£1M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
13 May 20196 years ago
Submission Deadline
Not specified
Future Notice Date
1 Jul 2019Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS GREATER GLASGOW AND CLYDE
Contact Name
Elizabeth McLaughlin
Contact Email
liz.mclaughlin@ggc.scot.nhs.uk
Contact Phone
+44 1412118794

Buyer Location

Locality
GLASGOW
Postcode
G4 0SF
Post Town
Glasgow
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM3 West Central Scotland
Small Region (ITL 3)
TLM32 Glasgow City
Delivery Location
TLM81 East Dunbartonshire, West Dunbartonshire, and Helensburgh and Lomond, TLM82 Glasgow City, TLM83 Inverclyde, East Renfrewshire, and Renfrewshire
Local Authority
Glasgow City
Electoral Ward
Dennistoun
Westminster Constituency
Glasgow North East

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139
    Oncotype DX Testing - NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000583062-2019-05-13T00:00:00Z",
    "date": "2019-05-13T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000583062",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-31",
            "name": "NHS Greater Glasgow and Clyde",
            "identifier": {
                "legalName": "NHS Greater Glasgow and Clyde"
            },
            "address": {
                "streetAddress": "Procurement Department, Glasgow Royal Infirmary, 84 Castle Street",
                "locality": "Glasgow",
                "region": "UKM82",
                "postalCode": "G4 0SF"
            },
            "contactPoint": {
                "name": "Elizabeth McLaughlin",
                "email": "liz.mclaughlin@ggc.scot.nhs.uk",
                "telephone": "+44 1412118794",
                "faxNumber": "+44 1412114682",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsggc.org.uk/"
            }
        }
    ],
    "buyer": {
        "name": "NHS Greater Glasgow and Clyde",
        "id": "org-31"
    },
    "planning": {
        "documents": [
            {
                "id": "MAY354139",
                "documentType": "plannedProcurementNotice",
                "title": "Oncotype DX Testing",
                "description": "NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "GGC0604",
        "title": "Oncotype DX Testing",
        "description": "NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.",
        "status": "planned",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "85121200",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "NHS Greater Glasgow and Clyde"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM82"
                    },
                    {
                        "region": "UKM81"
                    },
                    {
                        "region": "UKM83"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 875000,
            "currency": "GBP"
        },
        "mainProcurementCategory": "services",
        "lots": [
            {
                "id": "1",
                "description": "NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.",
                "status": "planned"
            }
        ],
        "communication": {
            "futureNoticeDate": "2019-07-01T00:00:00Z"
        },
        "coveredBy": [
            "GPA"
        ],
        "classification": {
            "id": "85121200",
            "scheme": "CPV"
        },
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=583062. (SC Ref:583062)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000583062"
        }
    ],
    "noticetype": "OJEU - F1 - Prior Information Notice"
}